Collaboration partners and funding sources

Heggebø LC, Borgen IMH, Blakstad H, Saxhaug C, Rønning PA, Niehusmann PF, Werlenius K, Blomstrand M, Brandal P (2025)
Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3
Front Oncol, 15, 1397912
DOI 10.3389/fonc.2025.1397912, PubMed 39949738

Liu Q, Fuster-Garcia E, Thokle Hovden I, MacIntosh BJ, Grodem EOS, Brandal P, Lopez-Mateu C, Sederevicius D, Skogen K, Schellhorn T, Bjornerud A, Eeg Emblem K (2025)
Treatment-Aware Diffusion Probabilistic Model for Longitudinal MRI Generation and Diffuse Glioma Growth Prediction
IEEE Trans Med Imaging, 44 (6), 2449-2462
DOI 10.1109/TMI.2025.3533038, PubMed 40031286

Mair MJ, Lohmann P, Galldiks N, Belting M, Brandal P, Broen MPG, Cicone F, Daisne JF, Ducray F, Ehret F, Furtner J, Jakola AS, Niyazi M, Pellerino A, Rasschaert M, Razis E, Sahm F, Smits M, Tolboom N, Verger A, Le Rhun E, Minniti G, Weller M, Preusser M, Albert NL (2025)
Availability and use of PET in patients with brain tumours - a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey
Eur J Nucl Med Mol Imaging (in press)
DOI 10.1007/s00259-025-07366-0, PubMed 40464806